Nano Delivery Strategy Opens Effective Avenues for the Treatment of Colorectal Cancer
ABSTRACT Colorectal cancer (CRC) presents significant therapeutic challenges because of chemoresistance, systemic toxicity, and the complexity of the tumor microenvironment (TME). Nanodrug delivery systems (NDDS) have emerged as versatile platforms capable of overcoming these limitations by enhancing tumor accumulation, improving pharmacokinetics, and ...
Qiurong Wei +7 more
wiley +1 more source
RETRACTION: Antiapoptotic and Antioxidant Properties of <i>Orthosiphon stamineus</i> Benth (Cat's Whiskers): Intervention in the Bcl-2-Mediated Apoptotic Pathway. [PDF]
And Alternative Medicine EC.
europepmc +1 more source
Apoptosis regulators of the Bcl-2 family play a key role in chemoresistance of cholangiocarcinoma organoids. [PDF]
Mi W +7 more
europepmc +1 more source
The BCL-2 protein family: from discovery to drug development. [PDF]
Croce CM +5 more
europepmc +1 more source
Targeting the WSB2-NOXA axis in cancer cells for enhanced sensitivity to BCL-2 family protein inhibitors. [PDF]
Jiao D +9 more
europepmc +1 more source
[Retracted] ABT‑737, a Bcl‑2 family inhibitor, has a synergistic effect with apoptosis by inducing urothelial carcinoma cell necroptosis. [PDF]
Cheng R, Liu X, Wang Z, Tang K.
europepmc +1 more source
Vitexin induces apoptosis and enhances daunorubicin efficacy in acute leukemia via modulation of the HIF-1α/Bcl-2/caspase-3 pathway. [PDF]
Jirawatpraphakorn C +3 more
europepmc +1 more source
Related searches:
Members of the Bcl-2 family of proteins are critical components in regulating the intrinsic apoptotic pathway. Bcl-2 protein overexpression is associated with drug resistance and poor clinical outcome in cancer patients. Preclinical and clinical evaluations demonstrate that downregulation of Bcl-2 restores the intrinsic apoptotic pathways with ...
Mehul P, Patel +3 more
openaire +2 more sources

